EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a clinical stage precision health company utilising Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, announces that its Board of Directors has today appointed Dr Per Walday as Chief Executive Officer (CEO). A successful senior executive .
/PRNewswire/ EXACT Therapeutics AS ("EXACT-Tx", Euronext Growth: EXTX), a clinical stage precision health company utilising Acoustic Cluster Therapy (ACT®).
EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) OSLO/LONDON, 22 December 2021: Christmas came early at EXACT Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX) as the clinical-stage precision health.
Underscores the Company's ambition to harness the power of ultrasound in precision therapeutics amplification OSLO, Norway and LONDON, Dec. 6, 2021 /PRNewswire/ Exact Therapeutics AS